Literature DB >> 6331710

Antibiotic treatment of Haemophilus influenzae and Haemophilus parainfluenzae infections in patients with cystic fibrosis.

T Pressler, M Szaff, N Høiby.   

Abstract

During the period 1977-81, 188 Cystic fibrosis patients have been treated with 1 254 anti-haemophilus treatments in the Danish Cystic Fibrosis Center. On an average, each patient received 1.7 courses of chemotherapy per year. Haemophilus infections were more prevalent in the youngest age group of patients. The average number of H. influenzae precipitins increased with age, and this pattern was consistent throughout the whole study. The standard treatment was orally administered pivampicillin or amoxicillin given for 14 days. 1 case of allergy or ampicillin-resistant strains, erythromycin was given, in most cases alone, in some cases in combination with rifampicin. The overall results showed, that H. influenzae was eradicated from sputum by a single course of chemotherapy in 73% of the courses and H. parainfluenzae in 100% of the courses. Six per cent of the patients suffered from chronic H. influenzae infection in spite of repeated treatments. No decrease of treatment efficiency was found even after many repeated chemotherapy courses. The prevalence of patients harbouring ampicillin-resistant H. influenzae increased in the beginning of the period (6%-20%), but a slight fall was subsequently observed.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6331710     DOI: 10.1111/j.1651-2227.1984.tb09968.x

Source DB:  PubMed          Journal:  Acta Paediatr Scand        ISSN: 0001-656X


  7 in total

Review 1.  Clinical significance of microbial infection and adaptation in cystic fibrosis.

Authors:  Alan R Hauser; Manu Jain; Maskit Bar-Meir; Susanna A McColley
Journal:  Clin Microbiol Rev       Date:  2011-01       Impact factor: 26.132

2.  Efficacy of oral fluoroquinolones versus conventional intravenous antipseudomonal chemotherapy in treatment of cystic fibrosis.

Authors:  T Jensen; S S Pedersen; N Høiby; C Koch
Journal:  Eur J Clin Microbiol       Date:  1987-12       Impact factor: 3.267

3.  Oral antimicrobial use in outpatient cystic fibrosis pulmonary exacerbation management: a single-center experience.

Authors:  Elissa Charlotte Briggs; Thuan Nguyen; Michael Abraham Wall; Kelvin David MacDonald
Journal:  Clin Respir J       Date:  2011-08-09       Impact factor: 2.570

4.  Haemophilus infection in cystic fibrosis.

Authors:  R J Rayner; E J Hiller; P Ispahani; M Baker
Journal:  Arch Dis Child       Date:  1990-03       Impact factor: 3.791

5.  N-acetyl-D-glucosamine medium improves recovery of Haemophilus influenzae from sputa of patients with cystic fibrosis.

Authors:  L V Möller; L van Alphen; H Grasselier; J Dankert
Journal:  J Clin Microbiol       Date:  1993-07       Impact factor: 5.948

Review 6.  Microbiology of airway disease in patients with cystic fibrosis.

Authors:  P H Gilligan
Journal:  Clin Microbiol Rev       Date:  1991-01       Impact factor: 26.132

7.  Haemophilus influenzae is frequently detected with monoclonal antibody 8BD9 in sputum samples from patients with cystic fibrosis.

Authors:  L V Möller; G J Ruijs; H G Heijerman; J Dankert; L van Alphen
Journal:  J Clin Microbiol       Date:  1992-09       Impact factor: 5.948

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.